Bessemer Group’s Evolus EOLS Stock Holding History

Bessemer Group’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-135	Closed	-$2K	–	2454
2025 Q1	$2K	Sell	135 -10	-7%	-$131	﹤0.01%	2219
2024 Q4	$2K	Hold	145	–	–	﹤0.01%	2203
2024 Q3	$2K	Buy	+145	New	+$2.03K	﹤0.01%	2192

Other funds holding EOLS

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bessemer Group's EOLS Position: Q2 2025 in Review

Bessemer Group sold out of Evolus (EOLS) in Q2 2025, closing a stake of 135 shares — an estimated $2K sold.

Bessemer Group first reported a position in EOLS in Q3 2024 and held it in 3 quarters. The position peaked at $2K in Q1 2025. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

Bessemer Group reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
Bessemer Group sold 135 Evolus shares in Q2 2025, an estimated $2K.
Bessemer Group first reported a position in Evolus in Q3 2024 and held it in 3 quarters.
Bessemer Group's Evolus position peaked at $2K in Q1 2025.
172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on Bessemer Group's 13F filing for Q2 2025, filed 1 Aug 2025.